Detalhe da pesquisa
1.
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson's disease: opicapone versus entacapone.
J Neural Transm (Vienna)
; 130(7): 925-930, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036498
2.
The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use.
Acta Neurol Scand
; 143(1): 3-12, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32813911
3.
Drooling in Parkinson's Disease: Prevalence and Progression from the Non-motor International Longitudinal Study.
Dysphagia
; 35(6): 955-961, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130515
4.
The Prevalence of Parkinson's Disease in Poland: Regional and Sex-Related Differences.
J Parkinsons Dis
; 14(3): 521-532, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457147
5.
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience Study.
Clin Med (Lond)
; 24(3): 100209, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642613
6.
The multimodal effect of circadian interventions in Parkinson's disease: A narrative review.
Parkinsonism Relat Disord
; 110: 105309, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36797197
7.
Parkinson's disease and Covid-19: The effect and use of telemedicine.
Int Rev Neurobiol
; 165: 263-281, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208904
8.
Impact of Covid-19 on research and training in Parkinson's disease.
Int Rev Neurobiol
; 165: 283-305, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208905
9.
Covid-19 and Parkinson's disease: Acute clinical implications, long-COVID and post-COVID-19 parkinsonism.
Int Rev Neurobiol
; 165: 63-89, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208907
10.
Why do 'OFF' periods still occur during continuous drug delivery in Parkinson's disease?
Transl Neurodegener
; 11(1): 43, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229860
11.
Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson's disease.
J Neurol
; 269(3): 1566-1573, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34338858
12.
Clinical trajectories and biomarkers for weight variability in early Parkinson's disease.
NPJ Parkinsons Dis
; 8(1): 95, 2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35918350
13.
Hypothalamic pathology in Huntington disease.
Handb Clin Neurol
; 182: 245-255, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34266596
14.
How Time Rules: Diurnal Motor Patterns in de novo Parkinson's Disease.
J Parkinsons Dis
; 11(2): 695-702, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33523019
15.
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.
J Parkinsons Dis
; 11(2): 475-489, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386813
16.
Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?
Parkinsonism Relat Disord
; 89: 186-194, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362670
17.
Constipation is Associated with Development of Cognitive Impairment in de novo Parkinson's Disease: A Longitudinal Analysis of Two International Cohorts.
J Parkinsons Dis
; 11(3): 1209-1219, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843697
18.
Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms Profile.
J Pers Med
; 11(8)2021 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34442417
19.
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.
Brain Behav
; 11(5): e02086, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33645912
20.
Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life.
Sci Rep
; 11(1): 9611, 2021 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953218